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INTRODUCTION
With the widespread use of high-throughput sequencing and the rapid reduction in cost of genetic testing, the number of identified genetic variants has grown. Clinicians ordering genetic testing receive results on a large number of germline variants for a large number of patients. As new data accumulates, genetic variant interpretations may change: variants of unknown significance (VUS) can change to benign or pathogenic, and even pathogenic variants can change to benign. [1] [2] [3] It is therefore of utmost importance for genetic testing labs and physicians to regularly check their existing genetic variant classifications against a publicly available database (e.g., ClinVar) and other sources, to keep their interpretations up to date and inform patients of changes.
Three major challenges must be overcome to accomplish this task. To address these challenges, we developed a Python-based tool, Ask2Me
VarHarmonizer, that can be used to harmonize the different naming conventions of a unique variant into a single standardized name, automatically map it to a public variant archive, ClinVar, and return the naming and classification information. We applied this tool to a pilot variant dataset of more than 7000 variant submissions collected from 11 clinical sites.
MATERIALS AND METHODS
Design of Ask2Me VarHarmonizer. Our implementation is in two steps: 1) curating and preprocessing the original variant entries; 2) harmonizing variants and mapping to
ClinVar. The workflow is summarized in Fig 1 and described next through an example dataset.
Step 1: Variant curating and preprocessing
We collected original variant entries from participating practices using a common data collection form, with four required fields: "practice", "gene", "original variant name", and "original lab-reported classification", and four optional fields: "protein change", "transcript ID", "lab", and "test year". Definitions and examples for each field are in Table 1 .
The preprocessing steps include: (1) removal of incomplete variant entries: entries with missing or invalid information in at least one of the four required fields were removed (e.g. no data or "0" in the "original variant names" field, or no data or "?" in the "original lab classification" field); (2) optional filtering of genes according to user defined criteria:
this allows focusing on subsets of interest (e.g. cancer susceptibility genes).
Variants from lab reports are usually classified into five categories: benign, likely benign, VUS, likely pathogenic, and pathogenic. First, we consolidated the variant classifications into three categories (referred to as "lab-reported classifications"): benign, VUS, and pathogenic. This was done to emphasize major differences in classification for the same variant, (e.g., pathogenic and VUS) and de-emphasize minor differences, which are likely to have less clinical significance (e.g., benign and likely benign). Details regarding the classification consolidation are provided in Table S1 . Next, we removed duplicate entries, defined as any two variants having identical data in all the following fields: 1) "practice", 2) "gene", 3) "original variant name", and 4) "lab-reported classification".
Step 2: Variant harmonizing and mapping to ClinVar
We next mapped the variants to ClinVar to determine a single name for variants reported in multiple ways. We used the Entrez Direct application programming interface (API) to retrieve ClinVar 5 data.
The entire mapping process includes up to four mapping attempts, described below. ClinVar uniquely recognized this variant, a response was obtained and recorded as described in the first attempt. Variant entries without "protein change" information were considered unmappable, and their "corrected variant names" were stored in the "master variant names" field (Fig 1, M3 ). Fourth attempt: For those variants that had "protein change" information but were unmappable in the third attempt, we removed the "corrected variant name" from the query and attempted to remap them with the combination "gene", "protein change", and "transcript ID" (if available). Some "corrected variant names" may have been inaccurate and removing this field from the submission allowed us to attempt to map these variants. "master variant names" and "ClinVar classifications" were stored for the mappable variants, while the unmappable ones were considered unmappable, and their "corrected variant names" were stored in the "master variant names" field (Fig 1, M4) .
Eventually, we populate the "master variant names" field for all variants, either from ClinVar or from "corrected variant names". Code for this mapping procedure is available upon request.
Evaluating the impact of transcript reference sequence. As the transcript reference sequence associated with a variant may not always be available, we validated the impact of missing transcript reference sequences, by selecting a subset of variants with known "transcript ID", and comparing the mapping results with and without "transcript ID".
Identifying unique variants and assessing multiple names. We defined a unique variant as a variant entry with unique "gene" and "master variant name" combination.
Some unique variants appeared multiple times in the dataset, with differing "original variant name" (e.g. "CHEK2: c.470T>C" had two "original variant names": "c.470T.C" in one practice and "c.470T)C" in another). We refer to these variants as those having multiple names. Unique variants with multiple names within a single practice are referred to as having within-practice multiple names (e.g. "MUTYH: c.1187G>A" has "original variant names": "1187G>A", "c.1187G)A", and "c,1187G>A" in the same practice 
RESULTS
Variant preprocessing. In all, we collected 7496 variant entries in 132 genes from 11 practices (test period: 1996--2019). We removed variant entries lacking information or contained invalid information in any required field (n=47). We also excluded an additional 530 variant entries in genes other than the 49 of interest, and 892 variant entries with data in the combination "practice", "gene", "original variant name", and "labreported classification". A total of 6027 variant entries (80.4% of the total submission) entered the mapping process (Fig 2, Step 1).
Variant harmonizing and mapping results.
The 6027 variant entries selected in step 1 underwent four attempts at variant harmonization and mapping (Fig 2, Step 2 (Fig 3) . The five genes with the largest number of unique variants were: BRCA2 (n = 601), ATM (n = 440), BRCA1 (n = 421), APC (n = 265), and MSH6 (n = 237). The number of unique variants for each gene is summarized in Table S2 . Among all unique variants, 474 (9.9%) were found at multiple practices (373 at 2 practices, 73 at 3 practices, and 28 at more than 3 practices). 427 (8.9%) unique variants had multiple names, 343 of which had within-practice multiple names.
Association between mapping rate and ClinVar variants count for each gene.
With the exception of EPCAM, all genes had a mappable rate greater than 0.6 (Fig 3) . The mappable rate and total number of variants in ClinVar for each gene are shown in Fig 4 (we excluded EPCAM as 0 out of 6 EPCAM variants were mappable).
We fit a Poisson model regressing the total number of variants in ClinVar against the mapping rate for the remaining 48 genes. We found a significant negative association.
The coefficient for the mapping rate is -2.68 (95% CI: -2.74, -2.61), implying that a 0.1 increase in mapping rate, corresponds on average to a decrease by 0.268 in the log count of the total number of variants in ClinVar.
DISCUSSION
We developed a python-based tool, Ask2Me VarHarmonizer, that harmonizes the naming of variants collected from clinical practices and maps these variants to ClinVar.
We applied this tool to over 7000 variant reports collected from 11 clinical practices. Of Our results from the pilot dataset demonstrated that 69.3% (n = 4178) of variants can be mapped to ClinVar in the first attempt of our four-attempt mapping tool (Fig 2) . For the remaining unmappable variants, their "original variant names" are likely to be nonstandard and therefore not recognized by ClinVar directly. Our tool automatically standardized the variant names to resolve the variabilities in variant naming, then mapped those standardized names ("corrected variant name") to ClinVar. We found that 7.3% (n = 437) of the total variants in the pilot dataset were mappable in our second attempt, showing that those variants were originally recorded in a less accurate, but typographical errors that cannot be corrected, e.g. "," in the nucleotide location.
In our study, we found that only half of the variant entries had transcript reference sequence information, though our validation test demonstrated that 98.6% of the time we obtained the same mapping results with or without the reference sequence. Our analysis showed that 9% of the unique variants we identified had multiple names. These differences in recording of variants make data consolidation challenging. Multiple patients in the same practice were found to have the same variant, but named differently. It would be ideal for practices to know which patients have the same variant in a gene. Linking these individuals (if related) can help find relatives that might otherwise be missed and help determine which bloodline the variant came through. For future research, obtaining the maximum number of people with a variant from each practice will aid the determination of classification and penetrance.
Our study also showed an inverse association between the mappable rate and the total number of variants in ClinVar. We conjecture that this inverse association may be associated with incomplete variant coverage in ClinVar. Although several commonly tested genes have been sequenced for decades, many variants, especially from legacy variants reports, were not submitted to ClinVar.
Our tool will be especially useful for low-resource clinical practices seeking to reevaluate their variant reports at no cost. We will incorporate it into our clinical decision The intent of our method is not to provide final adjudication of variant names or classifications but rather to identify probable variant names and discrepancies in classification and report back to each practice, with the expectation that each practice will then work with their lab or labs to adjudicate classifications. We hope that this will provide a feedback mechanism to increase our accuracy over time.
Remaining challenges in our computational pipeline are mapping capacity and accuracy given the available variant data. We are constantly improving our mapping algorithm and hope to encourage the participating practices to add unsubmitted variants to ClinVar.
The Ask2Me VarHarmonizer is designed to harmonize naming of variants across clinical practices and to map them to ClinVar. We expect that this tool will allow clinicians to harmonize their variant reports in an effective and efficient manner, to access the most up-to-date information from ClinVar, to identify discordant results that individual practices can adjudicate with their labs, and to record the variants in a more consistent and structured format, ultimately providing better care for patients. The current system that uses a variety of naming conventions runs the risk of inappropriately managing patients. Harmonization of naming conventions with our tool will increase the likelihood that a given patient with a given variant will be appropriately managed.
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